Digital health innovator Huma has sealed a five-year strategic global partnership with Atos to shift healthcare and clinical trials from hospital to home.  

The London-based HealthTech is also set to get a £17m investment from digital transformation consultancy Atos for R&D and go-to-market resources, including dedicated consulting and sales personnel.

This will help fast-track the integration of the Huma platform with other leading clinical platforms, as well as develop a dedicated video module.

The partnership will also support pharmaceutical and research industries to run complex global decentralised clinical trials. The platform is already used in the US and across Europe for illnesses ranging from atrial fibrillation to diabetes to COVID-19. 

The immense pressure exerted by the COVID-19 pandemic on the world’s healthcare systems exposed the weaknesses of current models already overstretched with ageing populations.  

Atos and Huma’s approach means patients are monitored outside of hospital and given timely, proactive clinical intervention ahead of need, ultimately optimising the use of resources, improving patient outcomes and reducing long-term healthcare costs.  

Early-stage evidence has shown Huma’s service, which has already been operating nationally across Germany, England and the UAE, can almost double hospital capacity. 


Robert Vassoyan, Head of Health & Life Sciences business, Atos, said: “We have great excitement about this partnership, as we are convinced that Atos and Huma can drive a systemic shift from reactive to proactive models of care.  

“Huma is the company we’ve been looking for in this important mission that resonates with each of us personally as we seek to improve the lives of our family, friends, neighbors and society.  

“This is a partnership worthy of the mission.” 

Dan Vahdat, CEO and founder of Huma, said: “This partnership takes us to a new league – we have already shown that we can create a service for a new disease area in a matter of weeks, as we did during the pandemic, and that we can go live with over 100 clinics in a day.  

“Atos will supercharge our work so we can offer services at scale, anywhere in the world across delivery of care and pharma collaborations leading to more people living longer, fuller lives.” 

The partnership will benefit from Huma’s software platform and 40+ patents, and Atos’ extensive professional service expertise in digital strategy, change management and service management. 

The companies say they conservatively expect the combined service will reach €100m revenue per year within the first four years.